Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk XBiotech Inc. per 2025 Jun 30 adalah -36.54 MM.
- Nilai net income untuk XBiotech Inc. per 2025 Jun 30 adalah -28.16 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -36.54 | -28.16 | |
2025-03-31 | -45.17 | -39.41 | |
2024-12-31 | -42.47 | -38.53 | |
2024-09-30 | -42.31 | -32.66 | |
2024-06-30 | -42.92 | -35.01 | |
2024-03-31 | -41.22 | -30.74 | |
2023-12-31 | -37.51 | -24.56 | |
2023-09-30 | 0.30 | -37.09 | -23.12 |
2023-06-30 | 1.98 | -34.95 | -28.42 |
2023-03-31 | 3.51 | -33.79 | -31.32 |
2022-12-31 | 4.01 | -34.49 | -32.90 |
2022-09-30 | 8.21 | -33.52 | -36.16 |
2022-06-30 | 11.05 | -30.86 | -26.77 |
2022-03-31 | 14.04 | -29.37 | -20.24 |
2021-12-31 | 18.39 | -25.08 | -17.41 |
2021-09-30 | 19.16 | -22.81 | -12.79 |
2021-06-30 | 25.19 | -23.75 | -12.05 |
2021-03-31 | 36.17 | -19.66 | -13.78 |
2020-12-31 | 44.00 | -18.28 | -11.22 |
2020-09-30 | 38.73 | -26.66 | 677.11 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk XBiotech Inc. pada 2025 Jun 30 adalah -0.92.
- laba per saham yang terdilusi untuk XBiotech Inc. pada 2025 Jun 30 adalah -0.92.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -0.92 | -0.92 |
2025-03-31 | -1.29 | -1.29 |
2024-12-31 | -1.26 | -1.26 |
2024-09-30 | -1.07 | -1.08 |
2024-06-30 | -1.15 | -1.16 |
2024-03-31 | -1.01 | -1.01 |
2023-12-31 | -0.81 | -0.81 |
2023-09-30 | -0.76 | -0.76 |
2023-06-30 | -0.93 | -0.93 |
2023-03-31 | -1.03 | -1.03 |
2022-12-31 | -1.08 | -1.08 |
2022-09-30 | -1.19 | -1.19 |
2022-06-30 | -0.88 | -0.88 |
2022-03-31 | -0.67 | -0.67 |
2021-12-31 | -0.58 | -0.58 |
2021-09-30 | -0.43 | -0.43 |
2021-06-30 | -0.41 | -0.41 |
2021-03-31 | -0.47 | -0.47 |
2020-12-31 | -0.36 | -0.36 |
2020-09-30 | 20.03 | 16.45 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk XBiotech Inc. per 2025 Jun 30 adalah -25.09 MM.
- Nilai cash from investing activities untuk XBiotech Inc. per 2025 Jun 30 adalah -0.57 MM.
- Nilai kas dari aktivitas pendanaan untuk XBiotech Inc. per 2025 Jun 30 adalah -9.90 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -25.09 | -0.57 | -9.90 |
2025-03-31 | -30.48 | -1.14 | -9.86 |
2024-12-31 | -30.96 | -1.30 | 10.45 |
2024-09-30 | -27.86 | -1.33 | 10.17 |
2024-06-30 | -23.50 | 60.83 | 10.11 |
2024-03-31 | -21.12 | 61.25 | 10.05 |
2023-12-31 | -18.73 | 61.50 | -0.01 |
2023-09-30 | -18.46 | 57.70 | -0.01 |
2023-06-30 | -18.12 | -63.86 | -0.01 |
2023-03-31 | -14.51 | -63.74 | |
2022-12-31 | -14.82 | -63.89 | |
2022-09-30 | -13.42 | -60.46 | 0.03 |
2022-06-30 | -15.67 | -1.42 | -72.01 |
2022-03-31 | 62.51 | -3.05 | -68.03 |
2021-12-31 | 69.44 | -3.52 | -67.01 |
2021-09-30 | 70.81 | -5.27 | -67.19 |
2021-06-30 | 81.70 | -5.26 | 7.08 |
2021-03-31 | -2.67 | -3.98 | 3.38 |
2020-12-31 | -65.15 | -3.73 | -409.72 |
2020-09-30 | -68.50 | 673.49 | -406.40 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk XBiotech Inc. pada 2025 Jun 30 adalah 0.52.
- p/tbv untuk XBiotech Inc. pada 2025 Jun 30 adalah 0.52.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 0.52 | 0.52 | |
2025-03-31 | 0.52 | 0.52 | |
2024-12-31 | 0.65 | 0.65 | |
2024-09-30 | -6.27 | 1.12 | 1.12 |
2024-06-30 | -4.57 | 0.67 | 0.67 |
2024-03-31 | -9.91 | 1.11 | 1.11 |
2023-12-31 | -5.26 | 0.55 | 0.55 |
2023-09-30 | -4.42 | 0.55 | 0.55 |
2023-06-30 | -5.82 | 0.77 | 0.77 |
2023-03-31 | -3.19 | 0.44 | |
2022-12-31 | 0.44 | 0.44 | |
2022-09-30 | 0.43 | 0.43 | |
2022-06-30 | -8.47 | 0.65 | 0.65 |
2022-03-31 | -15.03 | 0.97 | 0.97 |
2021-12-31 | -26.49 | 1.24 | 1.24 |
2021-09-30 | -32.65 | 1.13 | 1.13 |
2021-06-30 | |||
2021-03-31 | -16.74 | 0.65 | 0.65 |
2020-12-31 | -20.08 | 0.65 | 0.65 |
2020-09-30 | 0.33 | 0.65 | 0.65 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk XBiotech Inc. pada 2025 Jun 30 adalah 0.72.
- EBIT (3 tahun) / EV untuk XBiotech Inc. pada 2025 Jun 30 adalah 0.61.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | 0.72 | 0.61 |
2025-03-31 | 0.57 | 0.49 |
2024-12-31 | 0.68 | 0.62 |
2024-09-30 | -0.85 | -0.78 |
2024-06-30 | 0.60 | 0.59 |
2024-03-31 | -0.56 | -0.64 |
2023-12-31 | 0.28 | 0.33 |
2023-09-30 | 1.44 | 1.45 |
2023-06-30 | -1.04 | -0.92 |
2023-03-31 | 0.64 | 0.50 |
2022-12-31 | 0.72 | -4.14 |
2022-09-30 | 0.29 | -1.94 |
2022-06-30 | 0.48 | -3.73 |
2022-03-31 | -1.03 | 9.18 |
2021-12-31 | -0.20 | 2.29 |
2021-09-30 | -0.23 | 2.92 |
2021-06-30 | ||
2021-03-31 | 1.67 | -24.54 |
2020-12-31 | 1.07 | -18.99 |
2020-09-30 | -52.98 | -16.54 |
Efektivitas Manajemen
- roa untuk XBiotech Inc. pada 2025 Jun 30 adalah -0.18.
- roe untuk XBiotech Inc. pada 2025 Jun 30 adalah -0.20.
- roic untuk XBiotech Inc. pada 2025 Jun 30 adalah -0.21.
- croic untuk XBiotech Inc. pada 2025 Jun 30 adalah -0.24.
- ocroic untuk XBiotech Inc. pada 2025 Jun 30 adalah -0.16.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.18 | -0.20 | -0.21 | -0.24 | -0.16 |
2025-03-31 | -0.17 | -0.18 | -0.20 | -0.14 | -0.16 |
2024-12-31 | -0.14 | -0.15 | -0.16 | -0.09 | -0.14 |
2024-09-30 | -0.15 | -0.16 | -0.17 | 0.22 | -0.11 |
2024-06-30 | -0.13 | -0.13 | -0.14 | 0.22 | -0.10 |
2024-03-31 | -0.10 | -0.10 | -0.11 | 0.20 | -0.09 |
2023-12-31 | -0.09 | -0.09 | -0.10 | 0.19 | -0.08 |
2023-09-30 | -0.11 | -0.11 | -0.12 | -0.36 | -0.08 |
2023-06-30 | -0.12 | -0.12 | -0.12 | -0.36 | -0.08 |
2023-03-31 | -0.12 | -0.12 | -0.13 | -0.33 | -0.06 |
2022-12-31 | -0.13 | -0.13 | -0.15 | -0.32 | -0.08 |
2022-09-30 | -0.10 | -0.10 | -0.15 | -0.32 | -0.08 |
2022-06-30 | -0.06 | -0.06 | -0.10 | -0.35 | -0.07 |
2022-03-31 | -0.05 | -0.05 | -0.08 | -0.03 | 0.24 |
2021-12-31 | -0.04 | -0.04 | -0.06 | -0.00 | 0.26 |
2021-09-30 | -0.04 | -0.03 | -0.05 | 0.00 | 0.23 |
2021-06-30 | -0.03 | -0.04 | -0.03 | 0.25 | 0.23 |
2021-03-31 | -0.04 | -0.04 | -0.04 | -0.00 | -0.01 |
2020-12-31 | -0.01 | -0.01 | -0.03 | -1.37 | -0.19 |
2020-09-30 | 10.16 | 10.48 | 1.96 | 0.57 | -0.20 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | 0.95 | -102.48 | -137.39 |
2024-03-31 | 0.95 | -81.86 | -125.03 |
2023-12-31 | 0.95 | -77.08 | -123.62 |
2023-09-30 | 0.88 | -14.35 | -17.65 |
2023-06-30 | 0.88 | -14.35 | -17.65 |
2023-03-31 | 0.84 | -8.92 | -9.63 |
2022-12-31 | 0.80 | -4.40 | -4.08 |
2022-09-30 | 0.77 | -4.40 | -4.08 |
2022-06-30 | 0.73 | -2.42 | -2.79 |
2022-03-31 | 0.68 | -1.44 | -2.09 |
2021-12-31 | 0.63 | -0.95 | -1.36 |
2021-09-30 | 0.39 | -0.67 | -1.19 |
2021-06-30 | 0.39 | -0.48 | -0.94 |
2021-03-31 | 0.25 | -0.38 | -0.54 |
2020-12-31 | 0.21 | -0.26 | -0.42 |
2020-09-30 | 0.17 | 17.48 | -0.69 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1626878 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |